Back to Search
Start Over
An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic.
- Source :
-
Vaccine [Vaccine] 2021 Jan 15; Vol. 39 (3), pp. 495-504. Date of Electronic Publication: 2020 Dec 09. - Publication Year :
- 2021
-
Abstract
- The addition of other respiratory illnesses such as flu could cripple the healthcare system during the coronavirus disease 2019 (COVID-19) pandemic. An annual seasonal influenza vaccine is the best way to help protect against flu. Fears of coronavirus have intensified the shortage of influenza shots in developing countries that hope to vaccinate many populations to reduce stress on their health services. We present an inventory-location mixed-integer linear programming model for equitable influenza vaccine distribution in developing countries during the pandemic. The proposed model utilizes an equitable objective function to distribute vaccines to critical healthcare providers and first responders, elderly, pregnant women, and those with underlying health conditions. We present a case study in a developing country to exhibit efficacy and demonstrate the optimization model's applicability.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Subjects :
- Aged
Aged, 80 and over
Female
Health Personnel
Humans
Influenza Vaccines administration & dosage
Influenza, Human prevention & control
Pregnancy
Vaccination
COVID-19 epidemiology
Developing Countries statistics & numerical data
Equipment and Supplies
Influenza Vaccines supply & distribution
Public Health methods
Subjects
Details
- Language :
- English
- ISSN :
- 1873-2518
- Volume :
- 39
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Vaccine
- Publication Type :
- Academic Journal
- Accession number :
- 33342632
- Full Text :
- https://doi.org/10.1016/j.vaccine.2020.12.022